Drug recall · January 5, 2022
Lidocaine Hydrochloride recall
Why: Superpotent Drug
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64
- Lots / codes
Lot #: 16345, Exp. Date 01/2024
- Quantity
- 6,816 bottles
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Distributed to a wholesaler in CO who further distributed Nationwide in the USA
- Initiated
- November 30, 2021 · Voluntary: Firm initiated
- Classified
- December 28, 2021
- Reported
- January 5, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.